"Lannett Company develops, manufactures, and distributes generic drugs for a wide range of diseases, from glaucoma to migraines to pain management. The company notched nine consecutive quarters of record net sales and a 3-year annual growth rate for earnings per share of 314% -- making it the No. 1 fastest growing company."
Lower priced generic drugs seem to be at the forefront of trying to reign in healthcare costs.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.